- Home
- RCON vs GALT Comparison
RCON vs GALT Comparison
Compare RCON & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- GALT
- Stock Information
- Founded
- RCON 2007
- GALT 2000
- Country
- RCON China
- GALT United States
- Employees
- RCON N/A
- GALT N/A
- Industry
- RCON Oilfield Services/Equipment
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- GALT Health Care
- Exchange
- RCON Nasdaq
- GALT Nasdaq
- Market Cap
- RCON 82.1M
- GALT 83.5M
- IPO Year
- RCON 2009
- GALT N/A
- Fundamental
- Price
- RCON $2.53
- GALT $2.79
- Analyst Decision
- RCON
- GALT Buy
- Analyst Count
- RCON 0
- GALT 2
- Target Price
- RCON N/A
- GALT $6.00
- AVG Volume (30 Days)
- RCON 19.9K
- GALT 664.5K
- Earning Date
- RCON 07-29-2025
- GALT 08-12-2025
- Dividend Yield
- RCON N/A
- GALT N/A
- EPS Growth
- RCON N/A
- GALT N/A
- EPS
- RCON N/A
- GALT N/A
- Revenue
- RCON $8,996,572.00
- GALT N/A
- Revenue This Year
- RCON N/A
- GALT N/A
- Revenue Next Year
- RCON $12.17
- GALT N/A
- P/E Ratio
- RCON N/A
- GALT N/A
- Revenue Growth
- RCON N/A
- GALT N/A
- 52 Week Low
- RCON $1.39
- GALT $0.73
- 52 Week High
- RCON $3.70
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- RCON 53.18
- GALT 68.94
- Support Level
- RCON $2.21
- GALT $2.77
- Resistance Level
- RCON $2.68
- GALT $2.97
- Average True Range (ATR)
- RCON 0.17
- GALT 0.20
- MACD
- RCON -0.02
- GALT 0.04
- Stochastic Oscillator
- RCON 61.76
- GALT 91.11
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.